explore -WSS

explore

author：explore 2025-09-28 17:43:41 - browse：414

Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT — Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Biden administration plans revamp of organ transplant system

WSS

Inside the rise of 'mukbang' eating videos

Novo: Oral version of Ozempic leads to 15% weight loss

Elevance, SCAN deals highlight health insurer acquisition scrutiny

A new drug could help frostbite victims avoid its ravages

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Surprise medical billing ban raises prices elsewhere

focus

explore

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Mom launches Girl Scout troop for LGBTQ youth in Texas

Trump demands the U.S. pay no more for drugs than other countries … again

Flagship Pioneering startup Sonata Therapeutics lays off 21

What does generative AI mean for health care? We asked experts

Living organ donors deserve priority status for transplants

Medicare proposal to cover medical devices draws a mixed reaction

Surprise medical billing ban raises prices elsewhere

Affirmative action in medical school literally saved lives

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

hotspot

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

FDA warns medical device makers about rise in fabricated data

Eli Lilly’s Mounjaro succeeds in second weight

FDA approves first new drug developed for postpartum depression

Eli Lilly’s Mounjaro succeeds in second weight

A public health expert passes on football's full body collisions for youths

hotspot

Wikipedia

hotspot

entertainment